Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Archives of General Surgery(Electronic Edition) ›› 2016, Vol. 10 ›› Issue (03): 200-204. doi: 10.3877/cma.j.issn.1674-0793.2016.03.009

Special Issue:

• Original Article • Previous Articles     Next Articles

Protective effects of dexmedetomidine on perioperative digestive function of patients with liver cir-rhosis

Wulin Tan1, Yunpeng Hua2, Chanyan Huang1, Weifeng Liu1,()   

  1. 1. Department of Anesthesiology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China
    2. Department of Hepatic Surgery, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China
  • Received:2016-03-08 Online:2016-06-01 Published:2016-06-01
  • Contact: Weifeng Liu
  • About author:
    Corresponding author: Liu Weifeng, Email:

Abstract:

Objective

To investigate the effect of dexmedetomidine on digestive functions after hepatectomy in patients with liver cirrhosis under general anesthesia.

Methods

In this prospective, randomized, double-blind investigation, fifty patients with liver cirrhosis undergoing elective hepatectomy were randomized into dexmedetomidine group and control group. General anesthesia was conducted with a target-controlled infusion of propofol at a plasma target concentration of 3-4 μg/ml, 3 μg/kg fentanyl, and 0.2 mg/kg cisatracurium. After tracheal intubation, anesthesia was maintained with a target-controlled infusion of propofol, remifentanil 0.1-0.3 μg·kg-1·min-1, and cisatracurium 5-10 mg boluses according to clinical needs. The dexmedetomidine group received a loading dose of 1 μg/kg dexmedetomidine over 15 min right after the intubation, then followed by a maintenance dose of 0.3 μg·kg-1·h-1 to the end of operation. In the control group, 0.9% sodium chloride was administered. Venous blood was collected at five time points: baseline (before surgery), 1, 6, 24, and 72 h after hepatectomy. The observation targets included the variables reflecting (1) intestinal injury: serum diamine oxidase (DAO) and D-lactic acid (LAC); (2) liver function: AST and ALT; (3) inflammatory response: TNF-α and IL-6; (4) oxidative stress: MDA.

Results

DAO activity and D-LAC levels were lower in the dexmedetomidine group than in the control group after liver reperfusion (P<0.05). Also, the biomarkers reflecting liver injury increased over time, but were lower in the dexmedetomidine group (P<0.05). And the variables reflecting inflammatory response and oxidative stress were lower in the dexmedetomidine group than in the control group after liver reperfusion (P<0.01).

Conclusions

Dexmedetomidine administered perioperatively attenuates intestinal and hepatic injury in patients with liver cirrhosis after hepatectomy under general anesthesia. The protective mechanism of dexmedetomidine against intestinal and hepatic injury has a close relationship with inhibition of systemic inflammatory response and oxidant stress.

Key words: Dexmedetomidine, Hepatectomy, Liver cirrhosis, Digestion

京ICP 备07035254号-20
Copyright © Chinese Archives of General Surgery(Electronic Edition), All Rights Reserved.
Tel: 020-87331056 E-mail: pwwxcma2007@126.com
Powered by Beijing Magtech Co. Ltd